Episode 116: AML Series, Pt. 2 - MDS/AML Diag...

This week, we turn our attention to what we do in the maintenance setting for management of myeloma. At this point, our patient has gone through initial therapy; for patients who are able to undergo a transplant, we have consolidated their disease with a transplant; and now, we w ...  Show more

Throughout this series, we have discussed that for eligible patients, the current standard of care is to take patients for autologous stem cell transplant as consolidation for their multiple myeloma. In this reboot episode, we sit down with two incredible hematologists who specia ...  Show more

Consultant Rheumatologist and co-host of the Medical Take podcast, Dr Arrian ...

Our second SABCS (San Antonio Breast Cancer Symposium) episode covers everything (else) you need to know from 2024.

In this episode, we dive into the role of trastuzumab deruxtecan in HR +ve, HER2 low cancers, perioperative atezolizumab in tnbc, the use of a novel A ...

<div><span class= "author-d-1gg9uz65z1iz85zgdz68zmqkz84zo2qowz82zpfz80zz75zz76zz88znwz72zz80zz89zz82zg1z84zvz79zz81zrl5z84zz90zz86zxlgz73zz76zn"> Welcome back to today's Friday Review where I'll be breaking down the best of the week!</span></div> <div> </div> <div> </div> <div><s ...  Show more

This is the last episode of our core curriculum series. In this episode we discuss cancer survivorship as it relates to gynecologic oncology. Additionally we provide a framework for surveillance visits as well the general timing based on primary malignancy. We also give a brief o ...  Show more